Great Point Partners LLC

Investment Portfolio & 13F Holdings Analysis

About

GREAT POINT PARTNERS LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 32 holdings worth $0.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "ASND",
  "CNTA",
  "ABVX",
  "DVAX",
  "MREO",
  "SMMT",
  "LEGN",
  "NGNE",
  "AKBA",
  "AMLX",
  "AUTL",
  null,
  "KALV",
  "UNCY",
  "IONS",
  "PMN",
  "RZLT",
  "ZURA",
  "UPB",
  "PLRX",
  "ACLX",
  "CNTX",
  "EOLS",
  "VRDN",
  "VYGR",
  "XENE",
  "IMVT",
  "PCVX",
  "BEAM",
  "CYTK",
  "DNTH"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 32
Total Value: 188796269
Accession Number: 0001172661-25-002331
Form Type: 13F-HR
CIK: great-point-partners
Manager Name: Great-Point-Partners

Data Enrichment

97% identified

31 identified1 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

32 positions • $188,796.269K total value

32 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 1 of 2

Sort by:

CYTOKINETICS INC

CYTK|23282W605

Shares:370.0K

Value:$14.9M

KalVista Pharmaceuticals, Inc.

KALV|483497103

Shares:1.0M

Value:$11.7M

Evolus, Inc.

EOLS|30052C107

Shares:944.7K

Value:$11.4M

Abivax S.A.

ABVX|00370M103

Shares:1.6M

Value:$10.2M

Viridian Therapeutics, Inc.\DE

VRDN|92790C104

Shares:750.0K

Value:$10.1M

Merus N.V.

MRUS|N5749R100

Shares:237.2K

Value:$10.0M

Akebia Therapeutics, Inc.

AKBA|00972D105

Shares:5.0M

Value:$9.5M

Xenon Pharmaceuticals Inc.

XENE|98420N105

Shares:245.3K

Value:$8.2M

Ascendis Pharma A/S

ASND|04351P101

Shares:50.0K

Value:$7.8M

DYNAVAX TECHNOLOGIES CORP

DVAX|268158201

Shares:595.9K

Value:$7.7M

IONIS PHARMACEUTICALS INC

IONS|462222100

Shares:250.0K

Value:$7.5M

Amylyx Pharmaceuticals, Inc.

AMLX|03237H101

Shares:1.8M

Value:$6.4M

Immunovant, Inc.

IMVT|45258J102

Shares:375.0K

Value:$6.4M

Unicycive Therapeutics, Inc.

UNCY|90466Y103

Shares:11.0M

Value:$6.3M

Neurogene Inc.

NGNE|64135M105

Shares:471.0K

Value:$5.5M

Dianthus Therapeutics, Inc. /DE/

DNTH|252828108

Shares:275.0K

Value:$5.0M

Summit Therapeutics Inc.

SMMT|86627T108

Shares:250.0K

Value:$4.8M

Legend Biotech Corp

LEGN|52490G102

Shares:138.2K

Value:$4.7M

Vaxcyte, Inc.

PCVX|92243G108

Shares:115.5K

Value:$4.4M

Autolus Therapeutics plc

AUTL|05280R100

Shares:2.7M

Value:$4.2M

Instrument	Shares		Other Manager	Value
CYTOKINETICS INC(CYTKcusip23282W605)	370.0K	QoQ +2.77% (-10.0K) YoY +82.98% (+167.8K)	All Managers (Combined)	$14.9M	QoQ -12.18% (-$2.1M) YoY +4.89% (+$693.9K)
KalVista Pharmaceuticals, Inc.(KALVcusip483497103)	1.0M	QoQ -43.23% (-772.6K) YoY NEW(+1.0M)	All Managers (Combined)	$11.7M	QoQ -22.66% (-$3.4M) YoY NEW(+$11.7M)
Evolus, Inc.(EOLScusip30052C107)	944.7K	QoQ +5.49% (+49.2K) YoY -61.43% (-1.5M)	All Managers (Combined)	$11.4M	QoQ +14.95% (+$1.5M) YoY -66.86% (-$22.9M)
Abivax S.A.(ABVXcusip00370M103)	1.6M	QoQ -0.63% (-10.4K) YoY -34.17% (-850.4K)	All Managers (Combined)	$10.2M	QoQ -15.15% (-$1.8M) YoY -71.22% (-$25.3M)
Viridian Therapeutics, Inc.\DE(VRDNcusip92790C104)	750.0K	QoQ 0.00% (-0) YoY -43.82% (-585.0K)	All Managers (Combined)	$10.1M	QoQ -29.68% (-$4.3M) YoY -56.75% (-$13.3M)
Merus N.V.(MRUScusipN5749R100)	237.2K	QoQ +50.01% (+79.1K) YoY +6.21% (-13.9K)	All Managers (Combined)	$10.0M	QoQ +50.15% (+$3.3M) YoY -0.72% (-$72.8K)
Akebia Therapeutics, Inc.(AKBAcusip00972D105)	5.0M	QoQ NEW(+5.0M) YoY NEW(+5.0M)	All Managers (Combined)	$9.5M	QoQ NEW(+$9.5M) YoY NEW(+$9.5M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	245.3K	QoQ 0.00% (-0) YoY -46.22% (-210.9K)	All Managers (Combined)	$8.2M	QoQ -14.41% (-$1.4M) YoY -58.09% (-$11.4M)
Ascendis Pharma A/S(ASNDcusip04351P101)	50.0K	QoQ NEW(+50.0K) YoY NEW(+50.0K)	All Managers (Combined)	$7.8M	QoQ NEW(+$7.8M) YoY NEW(+$7.8M)
DYNAVAX TECHNOLOGIES CORP(DVAXcusip268158201)	595.9K	QoQ -30.71% (-264.1K) YoY -52.89% (-669.0K)	All Managers (Combined)	$7.7M	QoQ -29.62% (-$3.3M) YoY -50.76% (-$8.0M)
IONIS PHARMACEUTICALS INC(IONScusip462222100)	250.0K	QoQ -50.49% (-255.0K) YoY NEW(+250.0K)	All Managers (Combined)	$7.5M	QoQ -57.27% (-$10.1M) YoY NEW(+$7.5M)
Amylyx Pharmaceuticals, Inc.(AMLXcusip03237H101)	1.8M	QoQ NEW(+1.8M) YoY NEW(+1.8M)	All Managers (Combined)	$6.4M	QoQ NEW(+$6.4M) YoY NEW(+$6.4M)
Immunovant, Inc.(IMVTcusip45258J102)	375.0K	QoQ NEW(+375.0K) YoY NEW(+375.0K)	All Managers (Combined)	$6.4M	QoQ NEW(+$6.4M) YoY NEW(+$6.4M)
Unicycive Therapeutics, Inc.(UNCYcusip90466Y103)	11.0M	QoQ 0.00% (-0) YoY NEW(+11.0M)	All Managers (Combined)	$6.3M	QoQ -27.61% (-$2.4M) YoY NEW(+$6.3M)
Neurogene Inc.(NGNEcusip64135M105)	471.0K	QoQ +6.36% (-28.2K) YoY -53.10% (-533.3K)	All Managers (Combined)	$5.5M	QoQ -45.51% (-$4.6M) YoY -89.21% (-$45.6M)
Dianthus Therapeutics, Inc. /DE/(DNTHcusip252828108)	275.0K	QoQ 0.00% (-0) YoY -56.00% (-350.0K)	All Managers (Combined)	$5.0M	QoQ -16.78% (-$1.0M) YoY -73.39% (-$13.8M)
Summit Therapeutics Inc.(SMMTcusip86627T108)	250.0K	QoQ NEW(+250.0K) YoY NEW(+250.0K)	All Managers (Combined)	$4.8M	QoQ NEW(+$4.8M) YoY NEW(+$4.8M)
Legend Biotech Corp(LEGNcusip52490G102)	138.2K	QoQ NEW(+138.2K) YoY NEW(+138.2K)	All Managers (Combined)	$4.7M	QoQ NEW(+$4.7M) YoY NEW(+$4.7M)
Vaxcyte, Inc.(PCVXcusip92243G108)	115.5K	QoQ NEW(+115.5K) YoY NEW(+115.5K)	All Managers (Combined)	$4.4M	QoQ NEW(+$4.4M) YoY NEW(+$4.4M)
Autolus Therapeutics plc(AUTLcusip05280R100)	2.7M	QoQ -9.32% (-280.5K) YoY +133.90% (-1.6M)	All Managers (Combined)	$4.2M	QoQ -40.18% (-$2.8M) YoY -43.17% (-$3.2M)